Showing results (101-110 of 109) with videos related to
Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 109 results.
Journal of Neural Transmission. Supplementum|January 1, 1994
Blood to brain iron uptake in one rhesus monkey using [Fe-52]-citrate and positron emission tomography (PET): influence of haloperidolK L Leenders, A Antonini, R Schwarzbach, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 9, 2000
The effect of Rituximab on patients with follicular and mantle-cell lymphoma. Swiss Group for Clinical Cancer Research (SAKK)M Ghielmini, S F Schmitz, K Bürki, et al.The European Journal of Neuroscience|April 1, 1996
Erythropoietin gene expression in human, monkey and murine brainH H Marti, R H Wenger, L A Rivas, et al.Familial Cancer|March 20, 2010
Novel one-stop multidisciplinary follow-up clinic significantly improves cancer risk management in BRCA1/2 carriersG Pichert, C Jacobs, I Jacobs, et al.British Journal of Haematology|April 7, 1999
A prospective study of risk-adapted therapy for large cell non-Hodgkin's lymphoma with VACOP-B followed by high-dose CBV and autologous progenitor cell transplantation for high-risk patients in remissionR A Stahel, L M Jost, T Kroner, et al.Journal of Medical Genetics|April 17, 2008
Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinicsA C Antoniou, R Hardy, L Walker, et al.Journal of Medical Genetics|November 11, 2008
Risk reducing mastectomy: outcomes in 10 European centresD G R Evans, A D Baildam, E Anderson, et al.British Journal of Cancer|August 27, 2009
The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriersO M Sinilnikova, A C Antoniou, J Simard, et al.British Journal of Cancer|November 19, 2009
Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA)A Osorio, R L Milne, G Pita, et al.Pageof 11